Last Updated on June 22, 2023

EMBO Molecular Medicine- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Wiley-Blackwell

Abbreviation: EMBO Mol. Med.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

9.42

SJR

 3.932

h-Index

 130

Rank

 389

Important Details

Title EMBO Molecular Medicine
Standard Abbreviation EMBO Mol. Med.
Type of Publication Journal
Discipline Molecular Medicine (Q1)
Impact Score 9.42
SCImago Journal Rank (SJR) 3.932
h-index 130
Overall Rank 389
Publisher Name Wiley-Blackwell
Publication Country United Kingdom
International Standard Serial Number (ISSN) 17574676, 17574684
Coverage and History 2009-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
4154

About EMBO Molecular Medicine


EMBO Molecular Medicine is a journal published by Wiley-Blackwell. This journal covers the area[s] related to Molecular Medicine, etc. The coverage history of this journal is as follows: 2009-2022. The rank of this journal is 389. This journal's impact score, h-index, and SJR are 9.42, 130, and 3.932, respectively. The ISSN of this journal is/are as follows: 17574676, 17574684.

The best quartile of EMBO Molecular Medicine is Q1. This journal has received a total of 4154 citations during the last three years (Preceding 2022).


EMBO Molecular Medicine Impact Score 2022-2023


The latest impact score (IS) of the EMBO Molecular Medicine is 9.42. It is computed in the year 2023 as per its definition and based on Scopus data. 9.42

It is decreased by a factor of around 1.26, and the percentage change is -11.8% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of EMBO Molecular Medicine Impact Score 2023


Impact Score 2022 of EMBO Molecular Medicine is 9.42. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of EMBO Molecular Medicine. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 9.42
2021 10.68
2020 8.86
2019 7.43
2018 9.15
2017 9.27
2016 8.35
2015 8.82
2014 7.77

EMBO Molecular Medicine h-index


  Table Setting

The h-index of EMBO Molecular Medicine is 130. By definition of the h-index, this journal has at least 130 published articles with more than 130 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




EMBO Molecular Medicine ISSN


The International Standard Serial Number (ISSN) of EMBO Molecular Medicine is/are as follows: 17574676, 17574684.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

EMBO Molecular Medicine Ranking and SCImago Journal Rank (SJR)


The EMBO Molecular Medicine is ranked 389 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 3.932.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


EMBO Molecular Medicine Publisher


Table Setting

The publisher of EMBO Molecular Medicine is Wiley-Blackwell. The publishing house of this journal is located in the United Kingdom. Its coverage history is as follows: 2009-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of EMBO Molecular Medicine is EMBO Mol. Med.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('EMBO Mol. Med.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in EMBO Molecular Medicine


If your area of research or discipline is related to Molecular Medicine, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of EMBO Molecular Medicine?

The latest impact score of EMBO Molecular Medicine is 9.42. It is computed in the year 2023.


What is the h-index of EMBO Molecular Medicine?

The latest h-index of EMBO Molecular Medicine is 130. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of EMBO Molecular Medicine?

The latest SCImago Journal Rank (SJR) of EMBO Molecular Medicine is 3.932. It is calculated in the year 2023.


What is the ranking of EMBO Molecular Medicine?

The latest ranking of EMBO Molecular Medicine is 389. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of EMBO Molecular Medicine?

EMBO Molecular Medicine is published by Wiley-Blackwell. The publication country of this journal is United Kingdom.


What is the abbreviation of EMBO Molecular Medicine?

This standard abbreviation of EMBO Molecular Medicine is EMBO Mol. Med..


Is "EMBO Molecular Medicine" a Journal, Conference or Book Series?

EMBO Molecular Medicine is a journal published by Wiley-Blackwell.


What is the scope of EMBO Molecular Medicine?

The scope of EMBO Molecular Medicine is as follows:

  • Molecular Medicine

For detailed scope of EMBO Molecular Medicine, check the official website of this journal.


What is the ISSN of EMBO Molecular Medicine?

The International Standard Serial Number (ISSN) of EMBO Molecular Medicine is/are as follows: 17574676, 17574684.


What is the best quartile for EMBO Molecular Medicine?

The best quartile for EMBO Molecular Medicine is Q1.


What is the coverage history of EMBO Molecular Medicine?

The coverage history of EMBO Molecular Medicine is as follows 2009-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Journal of Business Economics and Management Journal Vilnius Gediminas Technical University 10343 45 2.81
Clinical Medicine and Research Journal Marshfield Clinic 16602 60 1.06
Journal of Competition Law and Economics Journal Oxford University Press 14815 29 0.72
Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute Journal Hoikkaido Forest Products Research Institute 25369 4 0.00
Proceedings of the International Semiconductor Conference, CAS Conference And Proceedings Institute of Electrical and Electronics Engineers Inc. 25734 16 0.00
Epigenetics Journal Landes Bioscience 2362 105 4.11
Canadian Journal of Mathematics Journal Canadian Mathematical Society 3905 43 0.79
Journal of Evolutionary Psychology Journal Akademiai Kiado 28897 0 0.00
Himalayan Geology Journal Wadia Institute of Himalayan Geology 14451 16 1.41
Economics of Innovation and New Technology Journal Routledge 6153 62 3.55

Check complete list




EMBO Molecular Medicine Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 9.42
2021 10.68
2020 8.86
2019 7.43
2018 9.15
2017 9.27
2016 8.35
2015 8.82
2014 7.77



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

Biomolecular Detection and Quantification
Elsevier GmbH | Germany

See All